Skip to content

Main Navigation

Clinical Study

LevoCept IUD - Phase III

The LevoCept IUD is an investigational product that is being developed as a possible method of birth control. The LevoCept IUD (when inserted into the uterus) releases the birth control hormone, levonorgestrel. This method of birth control is similar to that used by currently approved hormonal IUDs including MIRENA®, LILETTA® , and SKYLA®. By contrast, the LevoCept IUD is made of a more flexible material with a spring-type shape, which conforms to the shape of your uterus with the goal of providing comfort during device insertion. The purpose of this study is to find out: If LevoCept is effective in preventing pregnancy How easy LevoCept is to put in your uterus If there are any effects of LevoCept on menstrual periods and bleeding The ability to become pregnant within a year after LevoCept is removed for those who decide to leave the study early to become pregnant How women tolerate LevoCept If there are safety issues associated with LevoCept


For more information contact:

Corinne Sexsmith
  (801) 213-2522

IRB#: IRB_00136600 | PI: Lori Gawron | Department: OBSTETRICS AND GYNECOLOGY | Approval Date: 2021-01-06 07:00:00
Specialties: OB/Gyn, General

Who can participate?

 Gender: Female

 Age: Over 18 years old

 Volunteers: Volunteers with special conditions

 Location: In Person

Will I be paid for my time?


Last Updated: 4/5/21